219 related articles for article (PubMed ID: 25129603)
1. Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.
Atluri P; Miller JS; Emery RJ; Hung G; Trubelja A; Cohen JE; Lloyd K; Han J; Gaffey AC; MacArthur JW; Chen CS; Woo YJ
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1090-7; discussion 1097-8. PubMed ID: 25129603
[TBL] [Abstract][Full Text] [Related]
2. Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.
Gaffey AC; Chen MH; Venkataraman CM; Trubelja A; Rodell CB; Dinh PV; Hung G; MacArthur JW; Soopan RV; Burdick JA; Atluri P
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1268-76. PubMed ID: 26293548
[TBL] [Abstract][Full Text] [Related]
3. Delivery of progenitor cells with injectable shear-thinning hydrogel maintains geometry and normalizes strain to stabilize cardiac function after ischemia.
Gaffey AC; Chen MH; Trubelja A; Venkataraman CM; Chen CW; Chung JJ; Schultz S; Sehgal CM; Burdick JA; Atluri P
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1479-1490. PubMed ID: 30579534
[TBL] [Abstract][Full Text] [Related]
4. Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections.
Hamdi H; Planat-Benard V; Bel A; Puymirat E; Geha R; Pidial L; Nematalla H; Bellamy V; Bouaziz P; Peyrard S; Casteilla L; Bruneval P; Hagège AA; Agbulut O; Menasché P
Cardiovasc Res; 2011 Aug; 91(3):483-91. PubMed ID: 21565832
[TBL] [Abstract][Full Text] [Related]
5. Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction.
Fitzpatrick JR; Frederick JR; McCormick RC; Harris DA; Kim AY; Muenzer JR; Gambogi AJ; Liu JP; Paulson EC; Woo YJ
J Thorac Cardiovasc Surg; 2010 Sep; 140(3):667-76. PubMed ID: 20363480
[TBL] [Abstract][Full Text] [Related]
6. Delayed delivery of endothelial progenitor cell-derived extracellular vesicles via shear thinning gel improves postinfarct hemodynamics.
Chung JJ; Han J; Wang LL; Arisi MF; Zaman S; Gordon J; Li E; Kim ST; Tran Z; Chen CW; Gaffey AC; Burdick JA; Atluri P
J Thorac Cardiovasc Surg; 2020 May; 159(5):1825-1835.e2. PubMed ID: 31353103
[TBL] [Abstract][Full Text] [Related]
7. Expanded human cord blood-derived endothelial progenitor cells salvage infarcted myocardium in rats with acute myocardial infarction.
Hu CH; Li ZM; Du ZM; Zhang AX; Rana JS; Liu DH; Yang DY; Wu GF
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):551-6. PubMed ID: 20529094
[TBL] [Abstract][Full Text] [Related]
8. Alignment of inducible vascular progenitor cells on a micro-bundle scaffold improves cardiac repair following myocardial infarction.
Jamaiyar A; Wan W; Ohanyan V; Enrick M; Janota D; Cumpston D; Song H; Stevanov K; Kolz CL; Hakobyan T; Dong F; Newby BZ; Chilian WM; Yin L
Basic Res Cardiol; 2017 Jul; 112(4):41. PubMed ID: 28540527
[TBL] [Abstract][Full Text] [Related]
9. Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction.
Chen CW; Wang LL; Zaman S; Gordon J; Arisi MF; Venkataraman CM; Chung JJ; Hung G; Gaffey AC; Spruce LA; Fazelinia H; Gorman RC; Seeholzer SH; Burdick JA; Atluri P
Cardiovasc Res; 2018 Jun; 114(7):1029-1040. PubMed ID: 29566124
[TBL] [Abstract][Full Text] [Related]
10. Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct.
Atluri P; Trubelja A; Fairman AS; Hsiao P; MacArthur JW; Cohen JE; Shudo Y; Frederick JR; Woo YJ
Circulation; 2013 Sep; 128(11 Suppl 1):S95-104. PubMed ID: 24030426
[TBL] [Abstract][Full Text] [Related]
11. Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells.
Xiong Q; Ye L; Zhang P; Lepley M; Swingen C; Zhang L; Kaufman DS; Zhang J
Circ Res; 2012 Aug; 111(4):455-68. PubMed ID: 22723295
[TBL] [Abstract][Full Text] [Related]
12. Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.
MacArthur JW; Purcell BP; Shudo Y; Cohen JE; Fairman A; Trubelja A; Patel J; Hsiao P; Yang E; Lloyd K; Hiesinger W; Atluri P; Burdick JA; Woo YJ
Circulation; 2013 Sep; 128(11 Suppl 1):S79-86. PubMed ID: 24030424
[TBL] [Abstract][Full Text] [Related]
13. Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine.
Gao L; Gregorich ZR; Zhu W; Mattapally S; Oduk Y; Lou X; Kannappan R; Borovjagin AV; Walcott GP; Pollard AE; Fast VG; Hu X; Lloyd SG; Ge Y; Zhang J
Circulation; 2018 Apr; 137(16):1712-1730. PubMed ID: 29233823
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function.
Suuronen EJ; Price J; Veinot JP; Ascah K; Kapila V; Guo XW; Wong S; Mesana TG; Ruel M
J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1249-58. PubMed ID: 17976457
[TBL] [Abstract][Full Text] [Related]
15. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
[TBL] [Abstract][Full Text] [Related]
16. Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.
Hiesinger W; Frederick JR; Atluri P; McCormick RC; Marotta N; Muenzer JR; Woo YJ
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1174-80. PubMed ID: 20951261
[TBL] [Abstract][Full Text] [Related]
17. Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis.
Frederick JR; Fitzpatrick JR; McCormick RC; Harris DA; Kim AY; Muenzer JR; Marotta N; Smith MJ; Cohen JE; Hiesinger W; Atluri P; Woo YJ
Circulation; 2010 Sep; 122(11 Suppl):S107-17. PubMed ID: 20837901
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function.
Zakharova L; Mastroeni D; Mutlu N; Molina M; Goldman S; Diethrich E; Gaballa MA
Cardiovasc Res; 2010 Jul; 87(1):40-9. PubMed ID: 20118202
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice.
Fujii H; Sun Z; Li SH; Wu J; Fazel S; Weisel RD; Rakowski H; Lindner J; Li RK
JACC Cardiovasc Imaging; 2009 Jul; 2(7):869-79. PubMed ID: 19608138
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model.
Schuh A; Liehn EA; Sasse A; Hristov M; Sobota R; Kelm M; Merx MW; Weber C
Basic Res Cardiol; 2008 Jan; 103(1):69-77. PubMed ID: 17999028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
